{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:45:18Z","timestamp":1785527118443,"version":"3.56.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08688-9","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:32:55Z","timestamp":1785144775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting injury-induced transglutaminase-2 activity with a cementoin\u2013SLPI fusion protein: a novel therapeutic strategy for alkali-induced corneal injury"],"prefix":"10.1186","volume":"24","author":[{"given":"Juan Pablo","family":"Salica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"Potilinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Guerrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo C.","family":"Maffia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Chuluyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan E.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"4","key":"8688_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0039-6257(96)00007-0","volume":"41","author":"MD Wagoner","year":"1997","unstructured":"Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol. 1997, Jan;41(4):275\u2013313. https:\/\/doi.org\/10.1016\/S0039-6257(96)00007-0.","journal-title":"Surv Ophthalmol"},{"issue":"13","key":"8688_CR2","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/s41433-024-03073-6","volume":"38","author":"N Cronbach","year":"2024","unstructured":"Cronbach N, Foot B, Scawn R. Severe ocular chemical injury in the UK: a British ophthalmological surveillance Unit study. Eye (Lond). 2024, Sep;38(13):2552\u201356. https:\/\/doi.org\/10.1038\/s41433-024-03073-6.","journal-title":"Eye (Lond)"},{"issue":"2","key":"8688_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/0974-620X.116624","volume":"6","author":"P Singh","year":"2013","unstructured":"Singh P, Tyagi M, Kumar Y, Gupta KK, Sharma PD. Ocular chemical injuries and their management. Oman J Ophthalmol. 2013, May;6(2):83\u201386. https:\/\/doi.org\/10.4103\/0974-620X.116624.","journal-title":"Oman J Ophthalmol"},{"issue":"4","key":"8688_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/archopht.1946.00890200430010","volume":"35","author":"WF Hughes","year":"1946","unstructured":"Hughes WF. Alkali burns of the eye. Arch Ophthalmol. 1946 Apr;35(4):423. https:\/\/doi.org\/10.1001\/archopht.1946.00890200430010.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"8688_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000093075","volume":"220","author":"N Ikeda","year":"2006","unstructured":"Ikeda N, Hayasaka S, Hayasaka Y, Watanabe K. Alkali Burns of the eye: effect of immediate copious irrigation with tap water on their severity. Ophthalmologica. 2006;220(4):225\u201328. https:\/\/doi.org\/10.1159\/000093075.","journal-title":"Ophthalmologica"},{"issue":"1","key":"8688_CR6","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1186\/s12967-025-07102-0","volume":"23","author":"M Xie","year":"2025","unstructured":"Xie M, Jie Y. Transforming corneal alkali burn treatment: unveiling mechanisms and pioneering therapies from bench to bedside. J Transl Med. 2025, Oct;23(1):1132. https:\/\/doi.org\/10.1186\/s12967-025-07102-0.","journal-title":"J Transl Med"},{"key":"8688_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.preteyeres.2015.07.002","volume":"49","author":"AV Ljubimov","year":"2015","unstructured":"Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015, Nov;49:17\u201345. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.07.002.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"8688_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/bjo.2009.173724","volume":"95","author":"N Gupta","year":"2011","unstructured":"Gupta N, Kalaivani M, Tandon R. Comparison of prognostic value of Roper Hall and dua classification systems in acute ocular burns. Br J Ophthalmol. 2011, Feb;95(2):194\u201398. https:\/\/doi.org\/10.1136\/bjo.2009.173724.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"8688_CR9","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/s0161-6420(80)35126-9","volume":"87","author":"RR Pfister","year":"1980","unstructured":"Pfister RR, Paterson CA. Ascorbic acid in the treatment of alkali burns of the eye. Ophthalmology. 1980, Oct;87(10):1050\u201357. https:\/\/doi.org\/10.1016\/s0161-6420(80)35126-9.","journal-title":"Ophthalmology"},{"issue":"2","key":"8688_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/08820538.2025.2535588","volume":"41","author":"M Rajarajan","year":"2026","unstructured":"Rajarajan M, Chavda VB, Murugesan V, Agarwal S. Chemical injuries classification and management \u2013 current perspectives. Semin Ophthalmol. 2026, Feb;41(2):235\u201349. https:\/\/doi.org\/10.1080\/08820538.2025.2535588.","journal-title":"Semin Ophthalmol"},{"issue":"5","key":"8688_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","volume":"57","author":"J-H Chang","year":"2012","unstructured":"Chang J-H, Garg NK, Lunde E, Han K-Y, Jain S, Azar DT. Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol. 2012, Sep;57(5):415\u201329. https:\/\/doi.org\/10.1016\/j.survophthal.2012.01.007.","journal-title":"Surv Ophthalmol"},{"key":"8688_CR12","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.2147\/OPTH.S235873","volume":"14","author":"M Soleimani","year":"2020","unstructured":"Soleimani M, Naderan M. Management strategies of ocular chemical burns: current perspectives. Clin Ophthalmol. Sep 2020;14:2687\u201399. https:\/\/doi.org\/10.2147\/OPTH.S235873.","journal-title":"OPTH"},{"issue":"3","key":"8688_CR13","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","volume":"11","author":"SA Gaballa","year":"2021","unstructured":"Gaballa SA, Kompella UB, Elgarhy O, Alqahtani AM, Pierscionek B, Alany RG, et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res. 2021, Jun;11(3):866\u201393. https:\/\/doi.org\/10.1007\/s13346-020-00843-z.","journal-title":"Drug Deliv Transl Res"},{"key":"8688_CR14","doi-asserted-by":"publisher","unstructured":"Mittal M, Tidake P, Kumar M. Emerging strategies in treating corneal alkali burns: a narrative review. Cureus. 2023, Oct;15(10):e47662. https:\/\/doi.org\/10.7759\/cureus.47662.","DOI":"10.7759\/cureus.47662"},{"issue":"3","key":"8688_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00003226-200304000-00021","volume":"22","author":"C Cursiefen","year":"2003","unstructured":"Cursiefen C, Chen L, Dana MR, Streilein JW. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea. 2003, Apr;22(3):273\u201381. https:\/\/doi.org\/10.1097\/00003226-200304000-00021.","journal-title":"Cornea"},{"issue":"10","key":"8688_CR16","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.3390\/ijms25105479","volume":"25","author":"\u0141 Drzyzga","year":"2024","unstructured":"Drzyzga \u0141, \u015apiewak D, Dorecka M, Wygl\u0119dowska-Promie\u0144ska D. Available therapeutic options for corneal neovascularization: a review. Int J Mol Sci. 2024 May;25(10):5479. https:\/\/doi.org\/10.3390\/ijms25105479.","journal-title":"IJMS"},{"issue":"10","key":"8688_CR17","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1080\/02713683.2017.1317817","volume":"42","author":"H Choi","year":"2017","unstructured":"Choi H, Phillips C, Oh JY, Stock EM, Kim D-K, Won J-K, et al. Comprehensive modeling of corneal alkali injury in the rat eye. Curr Eye Res. 2017 Oct;42(10):1348\u201357. https:\/\/doi.org\/10.1080\/02713683.2017.1317817.","journal-title":"Curr Eye Res"},{"key":"8688_CR18","doi-asserted-by":"publisher","first-page":"108089","DOI":"10.1016\/j.exer.2020.108089","volume":"197","author":"SE Wilson","year":"2020","unstructured":"Wilson SE. Corneal wound healing. Exp Eye Res. 2020, Aug;197:108089. https:\/\/doi.org\/10.1016\/j.exer.2020.108089.","journal-title":"Exp Eye Res"},{"issue":"5","key":"8688_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/BF02153659","volume":"223","author":"T Pahlitzsch","year":"1985","unstructured":"Pahlitzsch T, Sinha P. The alkali burned cornea: electron microscopical, enzyme histochemical, and biochemical observations. Graefe\u2019s Arch Clin Exp Ophthalmol. 1985;223(5):278\u201386. https:\/\/doi.org\/10.1007\/BF02153659.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"6","key":"8688_CR20","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.exer.2009.07.012","volume":"89","author":"Y Huo","year":"2009","unstructured":"Huo Y, Qiu W-Y, Pan Q, Yao Y-F, Xing K, Lou MF. Reactive oxygen species (ROS) are essential mediators in epidermal growth factor (EGF)-stimulated corneal epithelial cell proliferation, adhesion, migration, and wound healing. Exp Eye Res. 2009, Dec;89(6):876\u201386. https:\/\/doi.org\/10.1016\/j.exer.2009.07.012.","journal-title":"Exp Eye Res"},{"key":"8688_CR21","doi-asserted-by":"publisher","unstructured":"Tu Y, Luo Y, Zhao Q, Zeng Y, Leng K, Zhu M. Role of macrophage in ocular neovascularization. Heliyon. 2024, May;10(10):e30840. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30840.","DOI":"10.1016\/j.heliyon.2024.e30840"},{"issue":"1","key":"8688_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.22336\/rjo.2019.4","volume":"63","author":"Z Sharif","year":"2019","unstructured":"Sharif Z, Sharif W. Corneal neovascularization: updates on pathophysiology, investigations & management. Rom J Ophthalmol. 2019;63(1):15\u201322. https:\/\/doi.org\/10.22336\/rjo.2019.4.","journal-title":"rjo"},{"issue":"10","key":"8688_CR23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma IM. NF-\u03baB regulation in the immune system. Nat Rev Immunol. 2002, Oct;2(10):725\u201334. https:\/\/doi.org\/10.1038\/nri910.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"8688_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jtos.2012.04.001","volume":"10","author":"W Lan","year":"2012","unstructured":"Lan W, Petznick A, Heryati S, Rifada M, Tong L. Nuclear factor-\u03baB: central regulator in ocular surface inflammation and diseases. Ocul Surf. 2012, Jul;10(3):137\u201348. https:\/\/doi.org\/10.1016\/j.jtos.2012.04.001.","journal-title":"Ocul Surf"},{"issue":"1","key":"8688_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/bjo.87.1.101","volume":"87","author":"C Cursiefen","year":"2003","unstructured":"Cursiefen C. Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation. Br J Ophthalmol. 2003, Jan;87(1):101\u201306. https:\/\/doi.org\/10.1136\/bjo.87.1.101.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"8688_CR26","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1080\/09273948.2020.1870148","volume":"30","author":"A Shahriary","year":"2022","unstructured":"Shahriary A, Sabzevari M, Jadidi K, Yazdani F, Aghamollaei H. The role of inflammatory cytokines in neovascularization of chemical ocular injury. Ocul Immunol Inflamm. 2022, Jul;30(5):1149\u201361. https:\/\/doi.org\/10.1080\/09273948.2020.1870148.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"8688_CR27","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.3390\/ijms27042027","volume":"27","author":"K Qin","year":"2026","unstructured":"Qin K, Setter NW, Yu L, Vasi Z, Wu W, Hwang Y, et al. Matrix metalloproteinase 14 in corneal neovascularization. Int J Mol Sci. 2026 Feb;27(4):2027. https:\/\/doi.org\/10.3390\/ijms27042027.","journal-title":"IJMS"},{"issue":"5","key":"8688_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/cbdd.13529","volume":"95","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wang S, He Y, Yao B, Zhang Y. Regulation of matrix metalloproteinases 2 and 9 in corneal neovascularization. Chem Biol Drug Des. 2020, May;95(5):485\u201392. https:\/\/doi.org\/10.1111\/cbdd.13529.","journal-title":"Chem Biol Drug Des"},{"key":"8688_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jtos.2024.06.003","volume":"34","author":"S Shen","year":"2024","unstructured":"Shen S, Zhang Y. Restoration of corneal epithelial barrier function: a possible target for corneal neovascularization. Ocul Surf. 2024, Oct;34:38\u201349. https:\/\/doi.org\/10.1016\/j.jtos.2024.06.003.","journal-title":"Ocul Surf"},{"issue":"12","key":"8688_CR30","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/eye.2015.172","volume":"29","author":"J Xiang","year":"2015","unstructured":"Xiang J, Le Q, Li Y, Xu J. In vivo confocal microscopy of early corneal epithelial recovery in patients with chemical injury. Eye (Lond). 2015, Dec;29(12):1570\u201378. https:\/\/doi.org\/10.1038\/eye.2015.172.","journal-title":"Eye (Lond)"},{"issue":"9","key":"8688_CR31","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/cells12091294","volume":"12","author":"L Sprogyte","year":"2023","unstructured":"Sprogyte L, Park M, Girolamo ND. Pathogenesis of alkali injury-induced limbal stem cell deficiency: a literature survey of animal models. Cells. 2023, May;12(9):1294. https:\/\/doi.org\/10.3390\/cells12091294.","journal-title":"Cells"},{"key":"8688_CR32","doi-asserted-by":"publisher","first-page":"101090","DOI":"10.1016\/j.preteyeres.2022.101090","volume":"91","author":"RR Mohan","year":"2022","unstructured":"Mohan RR, Kempuraj D, D\u2019Souza S, Ghosh A. Corneal stromal repair and regeneration. Prog Retin Eye Res. 2022, Nov;91:101090. https:\/\/doi.org\/10.1016\/j.preteyeres.2022.101090.","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"8688_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.12.12.12","volume":"12","author":"A Shadmani","year":"2023","unstructured":"Shadmani A, Ercal O, Uzun S, Swarup A, Wu AY. Regenerated corneal epithelium expresses more \u03b2III-Tubulin after chemical injuries compared to mechanical injuries. Trans Vis Sci Tech. 2023, Dec;12(12):12. https:\/\/doi.org\/10.1167\/tvst.12.12.12.","journal-title":"Trans Vis Sci Tech"},{"issue":"1","key":"8688_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.63.1.22","volume":"63","author":"SE Wilson","year":"2022","unstructured":"Wilson SE, Sampaio LP, Shiju TM, Hilgert GSL, de Oliveira RC. Corneal opacity: cell biological determinants of the transition from transparency to transient haze to scarring fibrosis, and resolution, after injury. Invest Ophthalmol Vis Sci. 2022, Jan;63(1):22. https:\/\/doi.org\/10.1167\/iovs.63.1.22.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"8688_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/02713683.2019.1663874","volume":"45","author":"N Lagali","year":"2020","unstructured":"Lagali N. Corneal stromal regeneration: current status and future therapeutic potential. Curr Eye Res. 2020, Mar;45(3):278\u201390. https:\/\/doi.org\/10.1080\/02713683.2019.1663874.","journal-title":"Curr Eye Res"},{"key":"8688_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.semcdb.2021.06.010","volume":"119","author":"P Martin","year":"2021","unstructured":"Martin P, Gurevich DB. Macrophage regulation of angiogenesis in health and disease. Semin Cell Dev Biol. 2021, Nov;119:101\u201310. https:\/\/doi.org\/10.1016\/j.semcdb.2021.06.010.","journal-title":"Semin Cell Dev Biol"},{"key":"8688_CR37","doi-asserted-by":"publisher","first-page":"114253","DOI":"10.1016\/j.jconrel.2025.114253","volume":"387","author":"X Qin","year":"2025","unstructured":"Qin X, Zhang L, Wang X, Meng J, Miao Y-B, Wang Q, et al. Harnessing engineered adaptive nanoparticles to modulate macrophages for treating corneal alkali burns. J Control Release. 2025, Nov;387:114253. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114253.","journal-title":"J Control Release"},{"issue":"5","key":"8688_CR38","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/s1350-9462(01)00008-8","volume":"20","author":"SE Wilson","year":"2001","unstructured":"Wilson SE, Mohan RR, Mohan RR, Ambr\u00f3sio R, Hong J, Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res. 2001, Sep;20(5):625\u201337. https:\/\/doi.org\/10.1016\/s1350-9462(01)00008-8.","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"8688_CR39","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1172\/JCI20465","volume":"113","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004, Apr;113(7):1040\u201350. https:\/\/doi.org\/10.1172\/JCI20465.","journal-title":"J Clin Invest"},{"key":"8688_CR40","doi-asserted-by":"publisher","unstructured":"Zhang Z, Zhao R, Wu X, Ma Y, He Y. Research progress on the correlation between corneal neovascularization and lymphangiogenesis (review). Mol Med Rep. 2024, Feb;31(2). https:\/\/doi.org\/10.3892\/mmr.2024.13412.","DOI":"10.3892\/mmr.2024.13412"},{"issue":"12","key":"8688_CR41","first-page":"2485","volume":"37","author":"MR Dana","year":"1996","unstructured":"Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci. 1996;37(12):2485\u201394.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"8688_CR42","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1001\/archopht.1978.03910060497024","volume":"96","author":"PC Donshik","year":"1978","unstructured":"Donshik PC, Berman MB, Dohlman CH, Gage J, Rose J. Effect of topical corticosteroids on ulceration in alkali-burned corneas. Archives Ophthalmol. 1978 Nov;96(11):2117\u201320. https:\/\/doi.org\/10.1001\/archopht.1978.03910060497024. Accessed Jul 14 2014. [Online]. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/214063.","journal-title":"Archives Ophthalmol"},{"issue":"4","key":"8688_CR43","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archophthalmol.2011.42","volume":"129","author":"D Hos","year":"2011","unstructured":"Hos D, et al. Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids. Arch Ophthalmol. 2011, Apr;129(4):445. https:\/\/doi.org\/10.1001\/archophthalmol.2011.42.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"8688_CR44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/01.icu.0000193079.55240.18","volume":"17","author":"R Jones","year":"2006","unstructured":"Jones R, Rhee DJ. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol. 2006, Apr;17(2):163\u201367. https:\/\/doi.org\/10.1097\/01.icu.0000193079.55240.18.","journal-title":"Curr Opin Ophthalmol"},{"issue":"11","key":"8688_CR45","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/bjo.76.11.681","volume":"76","author":"CN McGhee","year":"1992","unstructured":"McGhee CN. Pharmacokinetics of ophthalmic corticosteroids. Br J Ophthalmol. 1992, Nov;76(11):681\u201384. https:\/\/doi.org\/10.1136\/bjo.76.11.681.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"8688_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/2229-5178.85993","volume":"2","author":"JR Mandapati","year":"2011","unstructured":"Mandapati JR, Metta AK. Intraocular pressure variation in patients on long-term corticosteroids. Indian Dermatol Online J. 2011, Jul;2(2):67\u201369. https:\/\/doi.org\/10.4103\/2229-5178.85993.","journal-title":"Indian Dermatol Online J"},{"issue":"4","key":"8688_CR47","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","volume":"127","author":"MH Dastjerdi","year":"2009","unstructured":"Dastjerdi MH. Topical bevacizumab in the treatment of corneal neovascularization. Arch Ophthalmol. 2009 Apr;127(4):381. https:\/\/doi.org\/10.1001\/archophthalmol.2009.18.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"8688_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","volume":"10","author":"W Stevenson","year":"2012","unstructured":"Stevenson W, Cheng S-F, Dastjerdi MH, Ferrari G, Dana R. Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (lucentis) vs bevacizumab (avastin). Ocul Surf. 2012, Apr;10(2):67\u201383. https:\/\/doi.org\/10.1016\/j.jtos.2012.01.005.","journal-title":"Ocul Surf"},{"issue":"2","key":"8688_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nrm1014","volume":"4","author":"L Lorand","year":"2003","unstructured":"Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol. 2003, Feb;4(2):140\u201356. https:\/\/doi.org\/10.1038\/nrm1014.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"8688_CR50","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2741\/1843","volume":"11","author":"D Telci","year":"2006","unstructured":"Telci D. Tissue transglutaminase (TG2) - a wound response enzyme. Front Biosci. 2006 Jan;11(1):867\u201382. https:\/\/doi.org\/10.2741\/1843. [Online]. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16146777. Accessed Jul 27 2014.","journal-title":"Front Biosci"},{"issue":"1","key":"8688_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0197-0186(01)00064-x","volume":"40","author":"SY Kim","year":"2002","unstructured":"Kim SY, Jeitner TM, Steinert PM. Transglutaminases in disease. Neurochemistry Int. 2002 Jan;40(1):85\u2013103. https:\/\/doi.org\/10.1016\/s0197-0186(01)00064-x.","journal-title":"Neurochemistry Int"},{"issue":"2","key":"8688_CR52","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bbamcr.2011.09.012","volume":"1823","author":"S Gundemir","year":"2012","unstructured":"Gundemir S, Colak G, Tucholski J, Johnson GVW. Transglutaminase 2: a molecular Swiss army knife. Biochim et Biophys Acta (BBA) - Mol Cell Res. 2012 Feb;1823(2):406\u201319. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.09.012.","journal-title":"Biochim et Biophys Acta (BBA) - Mol Cell Res"},{"issue":"3","key":"8688_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1051\/bmdcn\/2017070315","volume":"7","author":"Z Szondy","year":"2017","unstructured":"Szondy Z, Korponay-Szab\u00f3 I, Kir\u00e1ly R, Sarang Z, Tsay GJ. Transglutaminase 2 in human diseases. Biomed (Taipei). 2017 Sep;7(3):15. https:\/\/doi.org\/10.1051\/bmdcn\/2017070315.","journal-title":"Biomed (Taipei)"},{"key":"8688_CR54","doi-asserted-by":"publisher","unstructured":"Tatsukawa H, Furutani Y, Hitomi K, Kojima S. Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death. Cell Death Dis. 2016 Jun;7(6):e2244. https:\/\/doi.org\/10.1038\/cddis.2016.150.","DOI":"10.1038\/cddis.2016.150"},{"key":"8688_CR55","doi-asserted-by":"publisher","first-page":"109338","DOI":"10.1016\/j.exer.2022.109338","volume":"226","author":"AL Minella","year":"2023","unstructured":"Minella AL, Casanova MI, Chokshi TJ, Kang J, Cosert K, Gragg MM, et al. The TGM2 inhibitor cysteamine hydrochloride does not impact corneal epithelial and stromal wound healing in vitro and in vivo. Exp Eye Res. 2023 Jan;226:109338. https:\/\/doi.org\/10.1016\/j.exer.2022.109338.","journal-title":"Exp Eye Res"},{"issue":"5","key":"8688_CR56","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/BF02175888","volume":"218","author":"B Samuelsson","year":"1982","unstructured":"Samuelsson B, Stenberg P, Pandolfi M. Localization and characteristics of transglutaminase in the rabbit and human eye. Graefe\u2019s Arch Clin Exp Ophthalmol. 1982;218(5):233\u201336. https:\/\/doi.org\/10.1007\/BF02175888.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"12","key":"8688_CR57","first-page":"2780","volume":"40","author":"M Raghunath","year":"1999","unstructured":"Raghunath M, Cankay R, Kubitscheck U, Fauteck JD, Mayne R, Aeschlimann D, et al. Transglutaminase activity in the eye: cross-linking in epithelia and connective tissue structures. Invest Ophthalmol Vis Sci. 1999 Nov;40(12):2780\u201387.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"8688_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1076\/ceyr.28.1.37.23493","volume":"28","author":"W Zhang","year":"2004","unstructured":"Zhang W, Shiraishi A, Suzuki A, Zheng X, Kodama T, Ohashi Y. Expression and distribution of tissue transglutaminase in normal and injured rat cornea. Curr Eye Res. 2004 Jan;28(1):37\u201345. https:\/\/doi.org\/10.1076\/ceyr.28.1.37.23493.","journal-title":"Curr Eye Res"},{"issue":"10","key":"8688_CR59","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1167\/iovs.06-0412","volume":"47","author":"L Tong","year":"2006","unstructured":"Tong L, Chen Z, Paiva CSD, Beuerman R, Li D-Q, Pflugfelder SC. Transglutaminase participates in UVB-induced cell death pathways in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4295\u2013301. https:\/\/doi.org\/10.1167\/iovs.06-0412.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"8688_CR60","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1167\/iovs.05-1129","volume":"47","author":"L Tong","year":"2006","unstructured":"Tong L, Corrales RM, Chen Z, Villarreal AL, De Paiva CS, Beuerman R, et al. Expression and regulation of cornified envelope proteins in human corneal epithelium. Invest Ophthalmol Vis Sci. 2006 May;47(5):1938\u201346. https:\/\/doi.org\/10.1167\/iovs.05-1129.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"8688_CR61","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/jcp.22389","volume":"226","author":"E Png","year":"2011","unstructured":"Png E, Samivelu GK, Yeo SH, Chew J, Chaurasia SS, Tong L. Hyperosmolarity-mediated mitochondrial dysfunction requires transglutaminase-2 in human corneal epithelial cells. J Cellular Physiol. 2011 Mar;226(3):693\u201399. https:\/\/doi.org\/10.1002\/jcp.22389.","journal-title":"J Cellular Physiol"},{"key":"8688_CR62","doi-asserted-by":"publisher","unstructured":"Barathi VA, Weon SR, Tan QSW, Lin KJ, Tong L, Beuerman RW. Transglutaminases (TGs) in ocular and periocular tissues: effect of muscarinic agents on TGs in scleral fibroblasts. PLoS One. 2011 Jan;6(4):e18326. https:\/\/doi.org\/10.1371\/journal.pone.0018326.","DOI":"10.1371\/journal.pone.0018326"},{"issue":"11","key":"8688_CR63","doi-asserted-by":"publisher","first-page":"7330","DOI":"10.4049\/jimmunol.174.11.7330","volume":"174","author":"L Falasca","year":"2005","unstructured":"Falasca L, Iadevaia V, Ciccosanti F, Melino G, Serafino A, Piacentini M. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment. J Immunol. 2005 Jun;174(11):7330\u201340. https:\/\/doi.org\/10.4049\/jimmunol.174.11.7330.","journal-title":"J Immunol"},{"issue":"1","key":"8688_CR64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.imlet.2011.03.004","volume":"138","author":"Z Sarang","year":"2011","unstructured":"Sarang Z, K\u00f6r\u00f6sk\u00e9nyi K, Pallai A, Dur\u00f3 E, Melino G, Griffin M, et al. Transglutaminase 2 null macrophages respond to lipopolysaccharide stimulation by elevated proinflammatory cytokine production due to an enhanced \u03b1v\u03b23 integrin-induced SRC tyrosine kinase signaling. Immunol Lett. 2011 Jul;138(1):71\u201378. https:\/\/doi.org\/10.1016\/j.imlet.2011.03.004.","journal-title":"Immunol Lett"},{"key":"8688_CR65","doi-asserted-by":"publisher","unstructured":"Yang T, Zhou X, Li H, Fan F, Yang J, Lin X, et al. Elevated tissue transglutaminase levels in aqueous humor of congenital cataractous eyes with long axial length. Heliyon. 2023 Aug;9(8):e18709. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18709.","DOI":"10.1016\/j.heliyon.2023.e18709"},{"issue":"2","key":"8688_CR66","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1152\/physrev.00019.2013","volume":"94","author":"RL Eckert","year":"2014","unstructured":"Eckert RL, Kaartinen MT, Nurminskaya M, Belkin AM, Colak G, Johnson GVW, et al. Transglutaminase regulation of cell function. Physiol Rev. 2014 Apr;94(2):383\u2013417. https:\/\/doi.org\/10.1152\/physrev.00019.2013.","journal-title":"Physiol Rev"},{"key":"8688_CR67","doi-asserted-by":"publisher","unstructured":"Pinkas DM, Strop P, Brunger AT, Khosla C. Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol. 2007, Dec;5(12):e327. https:\/\/doi.org\/10.1371\/journal.pbio.0050327.","DOI":"10.1371\/journal.pbio.0050327"},{"issue":"43","key":"8688_CR68","doi-asserted-by":"publisher","first-page":"37866","DOI":"10.1074\/jbc.M111.287490","volume":"286","author":"X Jin","year":"2011","unstructured":"Jin X, Stamnaes J, Kl\u00f6ck C, DiRaimondo TR, Sollid LM, Khosla C. Activation of extracellular transglutaminase 2 by thioredoxin. J Biol Chem. 2011 Oct;286(43):37866\u201373. https:\/\/doi.org\/10.1074\/jbc.M111.287490.","journal-title":"J Biol Chem"},{"issue":"33","key":"8688_CR69","doi-asserted-by":"publisher","first-page":"25402","DOI":"10.1074\/jbc.M109.097162","volume":"285","author":"J Stamnaes","year":"2010","unstructured":"Stamnaes J, Pinkas DM, Fleckenstein B, Khosla C, Sollid LM. Redox regulation of transglutaminase 2 activity. J Biol Chem. 2010 Aug;285(33):25402\u201309. https:\/\/doi.org\/10.1074\/jbc.M109.097162.","journal-title":"J Biol Chem"},{"issue":"13","key":"8688_CR70","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1096\/fasebj.13.13.1787","volume":"13","author":"ZA Haroon","year":"1999","unstructured":"Haroon ZA, Hettasch JM, Lai TS, Dewhirst MW, Greenberg CS. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. Faseb J. 1999 Oct;13(13):1787\u201395. https:\/\/doi.org\/10.1096\/fasebj.13.13.1787.","journal-title":"Faseb J"},{"issue":"9","key":"8688_CR71","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1042\/BCJ20170601","volume":"475","author":"N Bianchi","year":"2018","unstructured":"Bianchi N, Beninati S, Bergamini CM. Spotlight on the transglutaminase 2 gene: a focus on genomic and transcriptional aspects. The Biochemical J. 2018 May;475(9):1643\u201367. https:\/\/doi.org\/10.1042\/BCJ20170601.","journal-title":"The Biochemical J"},{"issue":"4","key":"8688_CR72","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3390\/ijms22041897","volume":"22","author":"T Su","year":"2021","unstructured":"Su T, Qin X-Y, Furutani Y. Transglutaminase 2 as a Marker for inflammation and therapeutic target in sepsis. IJMS. 2021 Feb;22(4):1897. https:\/\/doi.org\/10.3390\/ijms22041897.","journal-title":"IJMS"},{"issue":"4","key":"8688_CR73","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00726-008-0190-y","volume":"36","author":"RJ Collighan","year":"2009","unstructured":"Collighan RJ, Griffin M. Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids. 2009 Apr;36(4):659\u201370. https:\/\/doi.org\/10.1007\/s00726-008-0190-y.","journal-title":"Amino Acids"},{"issue":"4","key":"8688_CR74","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1083\/jcb.148.4.825","volume":"148","author":"SS Akimov","year":"2000","unstructured":"Akimov SS, Krylov D, Fleischman LF, Belkin AM. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol. 2000 Feb;148(4):825\u201338. https:\/\/doi.org\/10.1083\/jcb.148.4.825.","journal-title":"J Cell Biol"},{"issue":"10","key":"8688_CR75","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.1074\/jbc.270.10.5654","volume":"270","author":"J-M Jeong","year":"1995","unstructured":"Jeong J-M, Murthy SNP, Radek JT, Lorand L. The Fibronectin-binding Domain of transglutaminase. J Biol Chem. 1995 Mar;270(10):5654\u201358. https:\/\/doi.org\/10.1074\/jbc.270.10.5654.","journal-title":"J Biol Chem"},{"issue":"6","key":"8688_CR76","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.bbamcr.2013.02.030","volume":"1833","author":"L Tong","year":"2013","unstructured":"Tong L, Png E, AiHua H, Yong SS, Yeo HL, Riau A, et al. Molecular mechanism of transglutaminase-2 in corneal epithelial migration and adhesion. Biochim et Biophys Acta (BBA) - Mol Cell Res. 2013 Jun;1833(6):1304\u201315. https:\/\/doi.org\/10.1016\/j.bbamcr.2013.02.030.","journal-title":"Biochim et Biophys Acta (BBA) - Mol Cell Res"},{"issue":"1","key":"8688_CR77","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.2741\/2030","volume":"11","author":"S-Y Kim","year":"2006","unstructured":"Kim S-Y. Transglutaminase 2 in inflammation. Front Biosci. 2006;11(1):3026. https:\/\/doi.org\/10.2741\/2030.","journal-title":"Front Biosci"},{"issue":"51","key":"8688_CR78","doi-asserted-by":"publisher","first-page":"53725","DOI":"10.1074\/jbc.M407627200","volume":"279","author":"J Lee","year":"2004","unstructured":"Lee J, Kim Y-S, Choi D-H, Bang MS, Han TR, Joh TH, et al. Transglutaminase 2 induces nuclear factor-\u03baB activation via a novel pathway in BV-2 microglia. J Biol Chem. 2004 Dec;279(51):53725\u201335. https:\/\/doi.org\/10.1074\/jbc.M407627200.","journal-title":"J Biol Chem"},{"key":"8688_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-394305-7.00001-X","volume":"294","author":"MV Nurminskaya","year":"2012","unstructured":"Nurminskaya MV, Belkin AM. Cellular functions of tissue transglutaminase. Int Rev Cell Mol Biol. 2012;294:1\u201397. https:\/\/doi.org\/10.1016\/B978-0-12-394305-7.00001-X.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"2\u20133","key":"8688_CR80","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00726-011-1008-x","volume":"42","author":"Z Wang","year":"2012","unstructured":"Wang Z, Griffin M. TG2, a novel extracellular protein with multiple functions. Amino Acids. 2012 Feb;42(2\u20133):939\u201349. https:\/\/doi.org\/10.1007\/s00726-011-1008-x.","journal-title":"Amino Acids"},{"issue":"3","key":"8688_CR81","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00726-016-2320-2","volume":"49","author":"N Agnihotri","year":"2017","unstructured":"Agnihotri N, Mehta K. Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target. Amino Acids. 2017 Mar;49(3):425\u201339. https:\/\/doi.org\/10.1007\/s00726-016-2320-2.","journal-title":"Amino Acids"},{"issue":"7","key":"8688_CR82","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.3390\/ijms27073247","volume":"27","author":"JP Salica","year":"2026","unstructured":"Salica JP, Potilinski MC, Ortiz G, Maffia PC, Guerrieri D, Chuluyan E, et al. Downregulation of the transglutaminase 2\u2013NF-\u03baB inflammatory axis by a fusion protein of cementoin and secretory leukocyte protease inhibitor reduces corneal angiogenesis. IJMS. 2026 Apr;27(7):3247. https:\/\/doi.org\/10.3390\/ijms27073247.","journal-title":"IJMS"},{"issue":"18","key":"8688_CR83","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1073\/pnas.83.18.6692","volume":"83","author":"RC Thompson","year":"1986","unstructured":"Thompson RC, Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA. 1986 Sep;83(18):6692\u201396. https:\/\/doi.org\/10.1073\/pnas.83.18.6692.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"8688_CR84","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/CS20050115","volume":"110","author":"SE Williams","year":"2006","unstructured":"Williams SE, Brown TI, Roghanian A, Sallenave J-M. SLPI and elafin: one glove, many fingers. Clin Sci (Lond). 2006 Jan;110(1):21\u201335. https:\/\/doi.org\/10.1042\/CS20050115.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"8688_CR85","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/BST0350273","volume":"35","author":"S Weldon","year":"2007","unstructured":"Weldon S, McGarry N, Taggart CC, McElvaney NG. The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses. Biochem Soc Trans. 2007 Apr;35(2):273\u201376. https:\/\/doi.org\/10.1042\/BST0350273.","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"8688_CR86","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.biochi.2007.09.007","volume":"90","author":"T Moreau","year":"2008","unstructured":"Moreau T, Baranger K, Dad\u00e9 S, Dallet-Choisy S, Guyot N, Zani M-L. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie. 2008 Feb;90(2):284\u201395. https:\/\/doi.org\/10.1016\/j.biochi.2007.09.007.","journal-title":"Biochimie"},{"issue":"6","key":"8688_CR87","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/BF02896185","volume":"25","author":"H Yizhen","year":"2005","unstructured":"Yizhen H, Haijiang Z, Xinchun X, Yang C, Yongjuan H, Zulian X. Inhibitory effect of tissue transglutaminase (tTG) antisense oligodeoxynucleotides on tTG expression in cultured bovine trabecular meshwork cells. J Huazhong Univ Sci Technol [Med Sci]. 2005 Nov;25(6):729\u201331. https:\/\/doi.org\/10.1007\/BF02896185.","journal-title":"J Huazhong Univ Sci Technol [Med Sci]"},{"issue":"4","key":"8688_CR88","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.exer.2011.06.011","volume":"93","author":"T Tovar-Vidales","year":"2011","unstructured":"Tovar-Vidales T, Clark AF, Wordinger RJ. Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells. Exp Eye Res. 2011 Oct;93(4):442\u201351. https:\/\/doi.org\/10.1016\/j.exer.2011.06.011.","journal-title":"Exp Eye Res"},{"key":"8688_CR89","doi-asserted-by":"publisher","unstructured":"Stockley RA. Neutrophils and protease\/antiprotease imbalance. Am J Respir Crit Care Med. 1999 Nov;160(Supplement_1):S49\u201352. https:\/\/doi.org\/10.1164\/ajrccm.160.supplement_1.13.","DOI":"10.1164\/ajrccm.160.supplement_1.13"},{"issue":"1","key":"8688_CR90","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1038\/s41598-020-60482-9","volume":"10","author":"L Averdunk","year":"2020","unstructured":"Averdunk L, R\u00fcckbeil MV, Zarbock A, Martin L, Marx G, Jalaie H, et al. SLPI - a biomarker of acute kidney injury after open and endovascular thoracoabdominal aortic aneurysm (TAAA) repair. Sci Rep. 2020 Feb;10(1):3453. https:\/\/doi.org\/10.1038\/s41598-020-60482-9.","journal-title":"Sci Rep"},{"issue":"6","key":"8688_CR91","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/SHK.0000000000001785","volume":"56","author":"D Guerrieri","year":"2021","unstructured":"Guerrieri D, Ambrosi NG, Romeo H, Salaberry J, Toniolo MF, Remolins C, et al. Secretory leukocyte proteinase inhibitor protects acute kidney injury through immune and non-immune pathways. Shock. 2021 Dec;56(6):1019\u201327. https:\/\/doi.org\/10.1097\/SHK.0000000000001785.","journal-title":"Shock"},{"issue":"4","key":"8688_CR92","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1172\/JCI115994","volume":"90","author":"NG McElvaney","year":"1992","unstructured":"McElvaney NG, Nakamura H, Birrer P, H\u00e9bert CA, Wong WL, Alphonso M, et al. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest. 1992 Oct;90(4):1296\u2013301. https:\/\/doi.org\/10.1172\/JCI115994.","journal-title":"J Clin Invest"},{"issue":"1","key":"8688_CR93","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000047744","volume":"13","author":"J I\u0142zecka","year":"2002","unstructured":"I\u0142zecka J, Stelmasiak Z. Increased serum levels of endogenous protectant secretory leukocyte protease inhibitor in acute ischemic stroke patients. Cerebrovasc Dis. 2002;13(1):38\u201342. https:\/\/doi.org\/10.1159\/000047744.","journal-title":"Cerebrovasc Dis"},{"issue":"6","key":"8688_CR94","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1046\/j.1523-1747.1998.00425.x","volume":"111","author":"M Wingens","year":"1998","unstructured":"Wingens M, van Bergen BH, van Vlijmen-Willems IMJJ, Zeeuwen PLJM, van Ruissen F, Schalkwijk J, et al. Induction of SLPI (ALP\/HUSI-I) in epidermal keratinocytes. J Invest Dermatol. 1998 Dec;111(6):996\u20131002. https:\/\/doi.org\/10.1046\/j.1523-1747.1998.00425.x.","journal-title":"The J Invest Dermatol"},{"key":"8688_CR95","doi-asserted-by":"publisher","unstructured":"Lai J, Basford JR, Pittelkow MR. Levels of secretory leukocyte protease inhibitor expression in acute wounds. J Wound Care. 2022 Jul;31(Sup7):S15\u201319. https:\/\/doi.org\/10.12968\/jowc.2022.31.Sup7.S15.","DOI":"10.12968\/jowc.2022.31.Sup7.S15"},{"key":"8688_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2009\/259393","volume":"2009","author":"VE Reviglio","year":"2009","unstructured":"Reviglio VE, Grenat A, Pegoraro F, Sambuelli RH, Rana T, Kuo IC. Secretory leukoprotease inhibitor: a native antimicrobial protein in the innate immune response in a rat model of S. aureus keratitis. J Ophthalmol. 2009;2009:1\u20135. https:\/\/doi.org\/10.1155\/2009\/259393.","journal-title":"J Ophthalmol"},{"key":"8688_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2007\/93857","volume":"2007","author":"VE Reviglio","year":"2007","unstructured":"Reviglio VE, Sambuelli RH, Olmedo A, Falco M, Echenique J, O\u2019Brien TP, et al. Secretory leukocyte protease inhibitor is an inducible antimicrobial peptide expressed in Staphylococcus aureus endophthalmitis. Mediat Inflamm. 2007;2007:1\u20136. https:\/\/doi.org\/10.1155\/2007\/93857.","journal-title":"Mediators Inflammation"},{"issue":"12","key":"8688_CR98","doi-asserted-by":"publisher","first-page":"20557","DOI":"10.3390\/molecules191220557","volume":"19","author":"N Pescosolido","year":"2014","unstructured":"Pescosolido N, Barbato A, Pascarella A, Giannotti R, Genzano M, Nebbioso M. role of protease-inhibitors in ocular diseases. Molecules. 2014 Dec;19(12):20557\u201369. https:\/\/doi.org\/10.3390\/molecules191220557.","journal-title":"Molecules"},{"issue":"4_Part_1","key":"8688_CR99","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1164\/ajrccm\/141.4_Pt_1.889","volume":"141","author":"A Gast","year":"1990","unstructured":"Gast A, Anderson W, Probst A, Nick H, Thompson RC, Eisenberg SP, et al. Pharmacokinetics and distribution of recombinant secretory leukocyte proteinase inhibitor in rats. Am Rev Respir Dis. 1990 Apr;141(4_Part_1):889\u201394. https:\/\/doi.org\/10.1164\/ajrccm\/141.4_Pt_1.889.","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"8688_CR100","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/MOG.0000000000000042","volume":"30","author":"P Giuffrida","year":"2014","unstructured":"Giuffrida P, Biancheri P, MacDonald TT. Proteases and small intestinal barrier function in health and disease. Curr Opin Gastroenterol. 2014 Mar;30(2):147\u201353. https:\/\/doi.org\/10.1097\/MOG.0000000000000042.","journal-title":"Curr Opin Gastroenterol"},{"issue":"3","key":"8688_CR101","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/oxfordjournals.jbchem.a124357","volume":"115","author":"K Nara","year":"1994","unstructured":"Nara K, Ito S, Ito T, Suzuki Y, Ghoneim MA, Tachibana S, et al. Elastase inhibitor Elafin is a New type of proteinase inhibitor which has a Transglutaminase-mediated anchoring sequence termed \u201cCementoin\u201d1. J Biochem. 1994 Mar;115(3):441\u201348. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a124357.","journal-title":"J Biochem"},{"issue":"16","key":"8688_CR102","doi-asserted-by":"publisher","first-page":"12028","DOI":"10.1016\/S0021-9258(19)50303-9","volume":"268","author":"HO Molhuizen","year":"1993","unstructured":"Molhuizen HO, Alkemade HA, Zeeuwen PL, de Jongh GJ, Wieringa B, Schalkwijk J. SKALP\/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. J Biol Chem. 1993 Jun;268(16):12028\u201332. https:\/\/doi.org\/10.1016\/S0021-9258(19)50303-9.","journal-title":"J Biol Chem"},{"issue":"3","key":"8688_CR103","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1042\/bj3400569","volume":"340","author":"J Schalkwijk","year":"1999","unstructured":"Schalkwijk J, Wiedow O, Hirose S. The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochemical J. 1999 Jun;340(3):569\u201377. https:\/\/doi.org\/10.1042\/bj3400569.","journal-title":"The Biochemical J"},{"key":"8688_CR104","doi-asserted-by":"publisher","unstructured":"Baranger K, Zani M-L, Labas V, Dallet-Choisy S, Moreau T. Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a Transglutaminase substrate. PLoS One. 2011 Jun;6(6):e20976. https:\/\/doi.org\/10.1371\/journal.pone.0020976.","DOI":"10.1371\/journal.pone.0020976"},{"issue":"1","key":"8688_CR105","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1038\/s41598-018-23680-0","volume":"8","author":"PC Maff\u00eda","year":"2018","unstructured":"Maff\u00eda PC, Guerrieri D, Villalonga X, Caro F, G\u00f3mez S, Tateosian N, et al. Cementoin\u2013SLPI fusion protein binds to human monocytes and epithelial cells and shows higher biological activity than SLPI. Sci Rep. 2018 Mar;8(1):5332. https:\/\/doi.org\/10.1038\/s41598-018-23680-0.","journal-title":"Sci Rep"},{"issue":"12","key":"8688_CR106","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1084\/jem.20050768","volume":"202","author":"CC Taggart","year":"2005","unstructured":"Taggart CC, Cryan S-A, Weldon S, Gibbons A, Greene CM, Kelly E, et al. Secretory leucoprotease inhibitor binds to NF-\u03baB binding sites in monocytes and inhibits p65 binding. J Exp Med. 2005 Dec;202(12):1659\u201368. https:\/\/doi.org\/10.1084\/jem.20050768.","journal-title":"J Exp Med"},{"issue":"6","key":"8688_CR107","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1128\/IAI.72.6.3684-3687.2004","volume":"72","author":"CM Greene","year":"2004","unstructured":"Greene CM, McElvaney NG, O\u2019Neill SJ, Taggart CC. Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells. Infect Immun. 2004 Jun;72(6):3684\u201387. https:\/\/doi.org\/10.1128\/IAI.72.6.3684-3687.2004.","journal-title":"Infect Immun"},{"issue":"1","key":"8688_CR108","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/iovs.65.1.21","volume":"65","author":"W Wang","year":"2024","unstructured":"Wang W, Deng M, Li M, Liu L, Zou J, Qian Y. Exploring corneal neovascularization: an integrated approach using transcriptomics and proteomics in an alkali burn mouse model. Invest Ophthalmol Vis Sci. 2024 Jan;65(1):21. https:\/\/doi.org\/10.1167\/iovs.65.1.21.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"43","key":"8688_CR109","doi-asserted-by":"publisher","first-page":"30707","DOI":"10.1074\/jbc.274.43.30707","volume":"274","author":"CA Gaudry","year":"1999","unstructured":"Gaudry CA, Verderio E, Aeschlimann D, Cox A, Smith C, Griffin M. Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal \u03b2-Sandwich Domain. J Biol Chem. 1999 Oct;274(43):30707\u201314. https:\/\/doi.org\/10.1074\/jbc.274.43.30707.","journal-title":"J Biol Chem"},{"key":"8688_CR110","doi-asserted-by":"publisher","unstructured":"Lan EPW. Recent advances: transglutaminase in ocular health and pathological processes. J Clin Exp Ophthalmol. 2011. https:\/\/doi.org\/10.4172\/2155-9570.s2-002.","DOI":"10.4172\/2155-9570.s2-002"},{"issue":"1","key":"8688_CR111","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3341\/kjo.1998.12.1.6","volume":"12","author":"YJ Kim","year":"1998","unstructured":"Kim YJ, Park ES, Song KY, Park SC, Kim JC. Glutathione transferase (class \u03c0) and tissue transglutaminase (Tgase C) expression in pterygia. Korean J Ophthalmol. 1998 Jun;12(1):6\u201313. https:\/\/doi.org\/10.3341\/kjo.1998.12.1.6.","journal-title":"Korean J Ophthalmol"},{"issue":"1","key":"8688_CR112","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/s1542-0124(12)70103-9","volume":"6","author":"J Chui","year":"2008","unstructured":"Chui J, Girolamo ND, Wakefield D, Coroneo MT. The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf. 2008 Jan;6(1):24\u201343. https:\/\/doi.org\/10.1016\/s1542-0124(12)70103-9.","journal-title":"Ocul Surf"},{"key":"8688_CR113","doi-asserted-by":"publisher","unstructured":"Riau AK, Wong TT, Finger SN, Chaurasia SS, Hou AH, Chen S, et al. Aberrant DNA methylation of matrix remodeling and cell adhesion related genes in pterygium. PLoS One. 2011 Feb;6(2):e14687. https:\/\/doi.org\/10.1371\/journal.pone.0014687.","DOI":"10.1371\/journal.pone.0014687"},{"key":"8688_CR114","doi-asserted-by":"publisher","unstructured":"Salica JP, Guerrieri D, Maffia P, Croxatto JO, Chuluyan HE, Gallo JE. Transglutaminase binding fusion protein linked to SLPI reduced corneal inflammation and neovascularization. BMC Ophthalmol. 2015;15(1). https:\/\/doi.org\/10.1186\/1471-2415-15-12.","DOI":"10.1186\/1471-2415-15-12"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08688-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08688-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08688-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:08:59Z","timestamp":1785521339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08688-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8688"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08688-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have given their consent to publish the article.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have been involved in the academic development of the cementoin\u2013SLPI fusion protein discussed in this review. This work is part of ongoing academic research and is not associated with any patents, commercial activities, or financial interests. The authors declare no competing financial interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"969"}}